{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T05:59:57Z","timestamp":1648619997629},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,15]],"date-time":"2015-08-15T00:00:00Z","timestamp":1439596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Brasileira de Reumatologia (English Edition)"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.rbre.2015.08.009","type":"journal-article","created":{"date-parts":[[2015,9,9]],"date-time":"2015-09-09T04:39:59Z","timestamp":1441773599000},"page":"131-137","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Indirect and direct costs of treating patients with ankylosing spondylitis in the Brazilian public health system"],"prefix":"10.1016","volume":"56","author":[{"given":"Valderilio Feij\u00f3","family":"Azevedo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chayanne N.","family":"Rossetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro G.","family":"Lorencetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana Y.","family":"Tramontin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruna","family":"Fornazari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denizar V.","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbre.2015.08.009_bib0115","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1590\/S0482-50042007000400001","article-title":"Consenso Brasileiro de Espondiloartropatias: Espondilite Anquilosante e Artrite Psori\u00e1sica. Diagn\u00f3stico e Tratamento \u2013 Primeira Revis\u00e3o","volume":"47","author":"Sampaio-Barros Percival","year":"2007","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.rbre.2015.08.009_bib0120","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/rheumatology\/34.4.301","article-title":"Diagnostic features of ankylosing spondylitis","volume":"34","author":"Dougados","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.rbre.2015.08.009_bib0125","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0889-857X(05)70036-3","article-title":"Ankylosing spondylitis: clinical features","volume":"24","author":"Van Der Linden","year":"1998","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.rbre.2015.08.009_bib0130","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00002281-200107000-00004","article-title":"HLA-B27 and genetic predisposing factors in spondyloarthropathies","volume":"13","author":"Reveille","year":"2001","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rbre.2015.08.009_bib0135","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1136\/ard.2005.046367","article-title":"Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis andsystemic lupus erythematosus in Germany","volume":"65","author":"Huscher","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rbre.2015.08.009_bib0140","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1590\/S0482-50042013000300009","article-title":"Variables related to work productivity loss in patients with ankylosing spondylitis","volume":"53","author":"Frauendorf","year":"2013","journal-title":"Rev Bras Reumatol"},{"issue":"6","key":"10.1016\/j.rbre.2015.08.009_bib0145","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/acr.22253","article-title":"Understanding presenteeism in patients with ankylosing spondylitis: contributing factors and association with sick leave","volume":"66","author":"Gordeev","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.rbre.2015.08.009_bib0150","first-page":"732","article-title":"The cost-effectiveness of infliximab (Remicade) in the treatment of ankylosing spondylitis in Canada","volume":"33","author":"Kobelt","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rbre.2015.08.009_bib0155","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/rheumatology\/keh271","article-title":"The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade)","volume":"43","author":"Kobelt","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rbre.2015.08.009_bib0160","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/ard.2004.032565","article-title":"Markov model into the cost-utility over five years of etanercept and infliximab compared with usual care in patients with active ankylosing spondylitis","volume":"65","author":"Boonen","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rbre.2015.08.009_bib0165","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/ard.62.8.732","article-title":"Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries","volume":"62","author":"Boonen","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rbre.2015.08.009_bib0170","first-page":"490","article-title":"Resource utilisation and cost of ankylosing spondylitis in Brazil","volume":"28","author":"Torres","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rbre.2015.08.009_bib0175","first-page":"657","article-title":"Development of a matrix of cost domains in economic evaluation of rheumatoid arthritis","volume":"28","author":"Merkesdal","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rbre.2015.08.009_bib0180","unstructured":"Agencia Nacional de Vigilancia Sanit\u00e1ria. Pre\u00e7o m\u00e1ximo de medicamentos por principio ativo para compras p\u00fablicas. Available from: http:\/\/s.anvisa.gov.br\/wps\/s\/r\/f6 [accessed 19.07.13]."},{"key":"10.1016\/j.rbre.2015.08.009_bib0185","unstructured":"Brazilian minimum wage. Available from: http:\/\/www.guiatrabalhista.com.br\/guia\/salario_minimo.htm [accessed 15.05.14]."},{"key":"10.1016\/j.rbre.2015.08.009_bib0195","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/ard.2011.151563","article-title":"Assessment of SpondyloArthritis International Society. 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis","volume":"70","author":"van der Heijde","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.rbre.2015.08.009_bib0190","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00393-009-0510-y","article-title":"Assessment of SpondyloArthritis international Society. ASAS classification criteria for axial spondyloarthritis","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.rbre.2015.08.009_bib0200","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/ard.2011.151027","article-title":"2010 update of the ASAS\/EULAR recommendations for the management of ankylosing spondylitis","volume":"70","author":"Braun","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rbre.2015.08.009_bib0205","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1590\/S0482-50042013000300003","article-title":"Recommendations for the management and treatment of ankylosing spondylitis","volume":"53","author":"Sampaio-Barros","year":"2013","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.rbre.2015.08.009_bib0210","unstructured":"Minist\u00e9rio da Sa\u00fade. Available in: http:\/\/200.214.130.94\/consultapublica\/index.php?modulo=display&sub=dsp_consulta [accessed 25.10.12]."},{"key":"10.1016\/j.rbre.2015.08.009_bib0215","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3346\/jkms.2014.29.2.190","article-title":"Cost-of-illness and quality of life in patients with ankylosing spondylitis at a tertiary hospital in Korea","volume":"29","author":"Lee","year":"2014","journal-title":"J Korean Med Sci"},{"issue":"Suppl. 2","key":"10.1016\/j.rbre.2015.08.009_bib0220","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1007\/s12306-013-0285-9","article-title":"Rehabilitation and surgical management of ankylosing spondylitis","volume":"97","author":"Lubrano","year":"2013","journal-title":"Musculoskelet Surg"}],"container-title":["Revista Brasileira de Reumatologia (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255502115000838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255502115000838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T16:20:35Z","timestamp":1537374035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2255502115000838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S2255502115000838"],"URL":"https:\/\/doi.org\/10.1016\/j.rbre.2015.08.009","relation":{},"ISSN":["2255-5021"],"issn-type":[{"value":"2255-5021","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indirect and direct costs of treating patients with ankylosing spondylitis in the Brazilian public health system","name":"articletitle","label":"Article Title"},{"value":"Revista Brasileira de Reumatologia (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbre.2015.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rbr.2015.06.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}